Citations Database

Submit Your Publication

GenScript services and products have been used extensively by scientists worldwide to improve their research efficiency. Here, we have collected a representation of citations for your reference.

Date from
Page: 11/803 Results per page
A Polyvalent Adhesin-Toxoid Multiepitope-Fusion-Antigen-Induced Functional Antibodies against Five Enterotoxigenic Adhesins (CS7, CS12, CS14, CS17, and CS21) but Not Enterotoxins (LT and STa)
Authors: Siqi Li, Hyesuk Seo, Ipshita Upadhyay, Weiping Zhang
Journal: Microorganisms
PubMed ID: 37894131
Doi: 10.3390/microorganisms11102473
Products & Services: Gene Synthesis   
Kaempferol inhibits SARS-CoV-2 invasion by impairing heptad repeats-mediated viral fusion
Authors: Junwei Gao , Can Cao , Mingfei Shi , Shihao Hong , Shijie Guo , Jing Li , Tengxiao Liang , Ping Song , Ruodan Xu , Ning Li
Journal: Phytomedicine .
PubMed ID: 37421767
Doi: 10.1016/j.phymed.2023.154942
Products & Services: Peptide Synthesis   Gene Synthesis   
An artificially split class 3 intein
Authors: Tia M Ariagno , John S Smetana , Christopher W Lennon
Journal: MicroPubl Biol .
PubMed ID: 37811346
Doi: 10.17912/micropub.biology.000977
Products & Services: Gene Synthesis   PCR Cloning and Subcloning   
Prime editor-mediated functional reshaping of ACE2 prevents the entry of multiple human coronaviruses, including SARS-CoV-2 variants
Authors: Wenwen Zhao, Jifang Li, Xiao Wang, Wei Xu, Bao-Qing Gao, Jiangchao Xiang, Yaofeng Hou, Wei Liu, Jing Wu, Qilian Qi, Jia Wei, Xiaoyu Yang, Lu Lu,Li Yang, Jia Chen, Bei Yang
Journal: MedComm.
Doi: 10.1002/mco2.356
A mechanism that ensures non-selective cytoplasm degradation by autophagy
Authors: Tetsuya Kotani, Yuji Sakai, Hiromi Kirisako, Chika Kakuta, Soichiro Kakuta, Yoshinori Ohsumi, Hitoshi Nakatogawa
Journal: Nat Commun
PubMed ID: 37726301
Doi: 10.1038/s41467-023-41525-x
Products & Services: Gene Synthesis   
Molecular basis for bacterial N-glycosylation by a soluble HMW1C-like N-glycosyltransferase
Authors: Beatriz Piniello, Javier Macías-León, Shun Miyazaki, Ana García-García, Ismael Compañón, Mattia Ghirardello, Víctor Taleb, Billy Veloz, Francisco Corzana, Atsushi Miyagawa, Carme Rovira, Ramon Hurtado-Guerrero
Journal: Nat Commun
PubMed ID: 37723184
Doi: 10.1038/s41467-023-41238-1
Products & Services: Gene Synthesis   
Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
Authors: Emily Maria Ploeg , Douwe Freerk Samplonius, Xiao Xiong , Xiurong Ke, Mark Alexander Johannes Martinus Hendriks , Isabel Britsch , Anne Paulien van Wijngaarden , Hao Zhang , Wijnand Helfrich
Journal: J Immunother Cancer .
PubMed ID: 37734877
Doi: 10.1136/jitc-2023-006837
Products & Services: Gene Synthesis   
Validation of flavivirus infectious clones carrying fluorescent markers for antiviral drug screening and replication studies
Authors: Liubov Cherkashchenko , Nathalie Gros, Alice Trausch, Aymeric Neyret, Mathilde Hénaut, Gregor Dubois, Matthieu Villeneuve, Christine Chable-Bessia, Sébastien Lyonnais, Andres Merits, Delphine Muriaux
Journal: Front Microbiol
PubMed ID: 37779700
Doi: 10.3389/fmicb.2023.1201640
Products & Services: Gene Synthesis   
Antibacterial Fusobacterium nucleatum-Mimicking Nanomedicine to Selectively Eliminate Tumor-Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer
Authors: Linfu Chen , Rui Zhao , Jingjing Shen , Nanhui Liu , Zixuan Zheng , Yu Miao , Jiafei Zhu , Lin Zhang , Yingyao Wang , Huapan Fang , Jun Zhou , Maoyi Li , Yang Yang , Zhuang Liu , Qian Chen
Journal: Adv Mater .
PubMed ID: 37722134
Doi: 10.1002/adma.202306281
Products & Services: Gene Synthesis   
LncRNA LINC01123 promotes malignancy of ovarian cancer by targeting hsa-miR-516b-5p/VEGFA
Authors: Bing Dong, Cuiping Li, Xiaomeng Xu, Yan Wang, Yuewen Li, Xingmei Li
Journal: Genes Genomics
PubMed ID: 37728844
Doi: 10.1007/s13258-023-01440-3
Products & Services: Gene Synthesis   
< 6 7 8 9 10 11 12 13 14 15 16 > Total Pages 803

Do you like the current new website?